The mTOR inhibitor rapamycin opposes carcinogenic changes to epidermal Akt1/PKBalpha isoform signaling.

Sully K, Akinduro O, Philpott MP, Naeem AS, Harwood CA, Reeve VE, O'Shaughnessy RF, Byrne C
Oncogene. 2013 Jul 4;32(27):3254-62. doi: 10.1038/onc.2012.338. Epub 2012 Aug 13. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.